Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian S J Blagg

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Current Topics in Medicinal Chemistry|November 21, 2009
Inhibition and function of heat shock proteins 70 and 90Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|December 22, 2022
Recent advances toward the development of Hsp90 C-terminal inhibitorsEva Amatya, Brian S J Blagg
Organic Letters|May 20, 2005
Radester, a novel inhibitor of the Hsp90 protein folding machineryGang Shen, Brian S J Blagg
Current Medicinal Chemistry|November 11, 2008
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocketAlison Donnelly, Brian S J Blagg
Organic Letters|February 24, 2006
A versatile approach toward the ansamycin antibioticsWeimin Peng, Brian S J Blagg
Tetrahedron Letters|July 2, 2009
Synthesis of a versatile metacyclophane macrolactamMingwen Wang, Brian S J Blagg
Advances in Experimental Medicine and Biology|April 17, 2020
The Right Tool for the Job: An Overview of Hsp90 InhibitorsJohn Koren, Brian S J Blagg
Cell Stress & Chaperones|March 9, 2026
The Evolution of Hsp90 C-terminal Inhibitors: From Novobiocin to Potential Clinical CandidatesXiaosheng Jiang, Brian S J Blagg
European Journal of Medicinal Chemistry|May 4, 2025
Glucose-regulated protein 94 (Grp94/gp96) in viral pathogenesis: Insights into its role and therapeutic potentialsHao Xu, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|December 14, 2012
Novobiocin analogues with second-generation noviose surrogatesHuiping Zhao, Brian S J Blagg
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Current Topics in Medicinal Chemistry|November 21, 2009
Inhibition and function of heat shock proteins 70 and 90Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|December 22, 2022
Recent advances toward the development of Hsp90 C-terminal inhibitorsEva Amatya, Brian S J Blagg
Organic Letters|May 20, 2005
Radester, a novel inhibitor of the Hsp90 protein folding machineryGang Shen, Brian S J Blagg
Current Medicinal Chemistry|November 11, 2008
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocketAlison Donnelly, Brian S J Blagg
Organic Letters|February 24, 2006
A versatile approach toward the ansamycin antibioticsWeimin Peng, Brian S J Blagg
Tetrahedron Letters|July 2, 2009
Synthesis of a versatile metacyclophane macrolactamMingwen Wang, Brian S J Blagg
Advances in Experimental Medicine and Biology|April 17, 2020
The Right Tool for the Job: An Overview of Hsp90 InhibitorsJohn Koren, Brian S J Blagg
Cell Stress & Chaperones|March 9, 2026
The Evolution of Hsp90 C-terminal Inhibitors: From Novobiocin to Potential Clinical CandidatesXiaosheng Jiang, Brian S J Blagg
European Journal of Medicinal Chemistry|May 4, 2025
Glucose-regulated protein 94 (Grp94/gp96) in viral pathogenesis: Insights into its role and therapeutic potentialsHao Xu, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|December 14, 2012
Novobiocin analogues with second-generation noviose surrogatesHuiping Zhao, Brian S J Blagg
Pageof 22